Literature DB >> 27452597

Risk Factors for Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) Acquisition Among Contacts of Newly Diagnosed CP-CRE Patients.

Anat Schwartz-Neiderman1, Tali Braun1, Noga Fallach1, David Schwartz2, Yehuda Carmeli1, Vered Schechner1.   

Abstract

OBJECTIVE Carbapenemase-producing carbapenem-resistant Enterobacteriaceae (CP-CRE) are extremely drug-resistant pathogens. Screening of contacts of newly identified CP-CRE patients is an important step to limit further transmission. We aimed to determine the risk factors for CP-CRE acquisition among patients exposed to a CP-CRE index patient. METHODS A matched case-control study was performed in a tertiary care hospital in Israel. The study population was comprised of patients who underwent rectal screening for CP-CRE following close contact with a newly identified CP-CRE index patient. Cases were defined as positive tests for CP-CRE. For each case patient, 2 matched controls were randomly selected from the pool of contacts who tested negative for CP-CRE following exposure to the same index case. Bivariate and multivariate analyses were conducted using conditional logistic regression. RESULTS In total, 53 positive contacts were identified in 40 unique investigations (896 tests performed on 735 contacts) between October 6, 2008, and June 7, 2012. bla KPC was the only carbapenemase identified. In multivariate analysis, risk factors for CP-CRE acquisition among contacts were (1) contact with an index patient for ≥3 days (odds ratio [OR], 9.8; 95% confidence interval [CI], 2.0-48.9), (2) mechanical ventilation (OR, 4.1; 95% CI, 1.4-11.9), and (3) carriage or infection with another multidrug-resistant organism (MDRO; OR, 2.6; 95% CI, 1.0-7.1). Among patients who received antibiotics, cephalosporins were associated with a lower risk of acquisition. CONCLUSIONS Patient characteristics (ventilation and carriage of another MDRO) as well as duration of contact are risk factors for CP-CRE acquisition among contacts. The role of cephalosporins requires further study. Infect Control Hosp Epidemiol 2016;1-7.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27452597     DOI: 10.1017/ice.2016.153

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  10 in total

1.  Impact of the Timing of Antibiotic Administration on Digestive Colonization with Carbapenemase-Producing Enterobacteriaceae in a Murine Model.

Authors:  Rémi Le Guern; Teddy Grandjean; Marvin Bauduin; Martin Figeac; Guillaume Millot; Aurore Loquet; Karine Faure; Eric Kipnis; Rodrigue Dessein
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

2.  A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae.

Authors:  Karlijn van Loon; Anne F Voor In 't Holt; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

3.  Transmission routes of antibiotic resistant bacteria: a systematic review.

Authors:  Noortje G Godijk; Martin C J Bootsma; Marc J M Bonten
Journal:  BMC Infect Dis       Date:  2022-05-20       Impact factor: 3.667

4.  Risk factors for Klebsiella pneumoniae carbapenemase (KPC) gene acquisition and clinical outcomes across multiple bacterial species.

Authors:  A J Mathers; K Vegesana; I German-Mesner; J Ainsworth; A Pannone; D W Crook; C D Sifri; A Sheppard; N Stoesser; T Peto; A S Walker; D W Eyre
Journal:  J Hosp Infect       Date:  2020-01-10       Impact factor: 3.926

5.  The influence of antibiotics on transitory resistome during gut colonization with CTX-M-15 and OXA-162 producing Klebsiella pneumoniae ST15.

Authors:  Balázs Stercz; Ferenc B Farkas; Ákos Tóth; Márió Gajdács; Judit Domokos; Viola Horváth; Eszter Ostorházi; Nóra Makra; Béla Kocsis; János Juhász; Balázs Ligeti; Sándor Pongor; Dóra Szabó
Journal:  Sci Rep       Date:  2021-03-18       Impact factor: 4.379

6.  Droplets generated from toilets during urination as a possible vehicle of carbapenem-resistant Klebsiella pneumoniae.

Authors:  Fabio Arena; Anna Rita Daniela Coda; Valentina Meschini; Roberto Verzicco; Arcangelo Liso
Journal:  Antimicrob Resist Infect Control       Date:  2021-10-20       Impact factor: 4.887

7.  A Retrospective Study of Risk Factors, Mortality, and Treatment Outcomes for Infections with Carbapenemase-Producing Enterobacterales in a Tertiary Hospital in Havana, Cuba.

Authors:  Haiyang Yu; Alberto Hernández González; Gonzalo Estévez Torres; María Karla González Molina; Marcia Hart Casares; Xu Han; Waldemar Baldoquín Rodríguez; Dianelys Quiñones Pérez
Journal:  Antibiotics (Basel)       Date:  2022-07-14

8.  Epidemiology and Transmission of Carbapenemase-Producing Enterobacteriaceae in a Health Care Network of an Acute-Care Hospital and Its Affiliated Intermediate- and Long-Term-Care Facilities in Singapore.

Authors:  Aung-Hein Aung; Kala Kanagasabai; Jocelyn Koh; Pei-Yun Hon; Brenda Ang; David Lye; Swaine L Chen; Angela Chow
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191

9.  Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from the European Centre for Disease Prevention and Control.

Authors:  A P Magiorakos; K Burns; J Rodríguez Baño; M Borg; G Daikos; U Dumpis; J C Lucet; M L Moro; E Tacconelli; G Skov Simonsen; E Szilágyi; A Voss; J T Weber
Journal:  Antimicrob Resist Infect Control       Date:  2017-11-15       Impact factor: 4.887

10.  Gut Colonization with Carbapenem-resistant Enterobacteriaceae Adversely Impacts the Outcome in Patients with Hematological Malignancies: Results of A Prospective Surveillance Study.

Authors:  Sarita Rani Jaiswal; Satyanker Gupta; Rekha Saji Kumar; Amit Sherawat; Ashok Rajoreya; Saroj K Dash; Gitali Bhagwati; Suparno Chakrabarti
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-05-01       Impact factor: 2.576

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.